Remove Drug Development Remove Health IT Remove Life Science Remove Pharmaceuticals
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. In fact, we got so many that we had to narrow them down to just the best and most interesting.

article thumbnail

Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

Healthcare IT Today

“Flywheel’s products transform healthcare innovation by empowering organizations to efficiently and securely ingest, curate and share medical imaging data for accelerated research and AI development,” said Flywheel CEO, Jim Olson. For more information visit novalislifesciences.com. Originally announced June 27th, 2023

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Atropos Health Announces Strategic Financing to Fund International Expansion and Support Key Channel Partnerships

Healthcare IT Today

Atropos Health offers the world’s first award-winning platform for faster data evaluation, evidence generation, and Generative AI innovation of research and care. This platform is designed to meet the demands of health systems and life science companies working to solve increasingly global, diverse, and data-intensive healthcare problems.

article thumbnail

Like banks, healthcare will become digital-first in 2022, Zoom healthcare lead says

Healthcare IT News - Telehealth

Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. You predict that decentralization will become a major theme for health and life science organizations. Please elaborate.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. She was the patient keynote speaker at DPHARM 2021 and is a HIMSS Digital Health Influencer. Connect with her at [link]. Did you enjoy this post?

BioTech 107
article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,